1 INTRODUCTION 1.1 Study Deliverables 1.2 Study Assumptions 1.3 Scope of the Study 2 RESEARCH METHODOLOGY 3 EXECUTIVE SUMMARY 3.1 Market Overview 4 MARKET DYNAMICS 4.1 Market Drivers 4.2 Market Restraints 4.3 Porters Five Forces Analysis 4.3.1 Threat of New Entrants 4.3.2 Bargaining Power of Buyers/Consumers 4.3.3 Bargaining Power of Suppliers 4.3.4 Threat of Substitute Products 4.3.5 Intensity of Competitive Rivalry 5 MARKET SEGMENTATION 5.1 By Type 5.1.1 Lysozyme 5.1.2 Avidin 5.1.3 Ovalbumin 5.1.4 Ovotransferrin 5.1.5 Other Types 5.2 By Application 5.2.1 Functional Food 5.2.2 Bakery and Confectionery 5.2.3 Beer and Beverage 5.2.4 Pharmaceuticals 5.2.5 Animal Nutrition 5.2.6 Cosmetics 5.3 Geography 5.3.1 North America 5.3.1.1 United States 5.3.1.2 Canada 5.3.1.3 Mexico 5.3.1.4 Rest of North America 5.3.2 Europe 5.3.2.1 Spain 5.3.2.2 United Kingdom 5.3.2.3 France 5.3.2.4 Germany 5.3.2.5 Russia 5.3.2.6 Italy 5.3.2.7 Rest of Europe 5.3.3 Asia-Pacific 5.3.3.1 China 5.3.3.2 Japan 5.3.3.3 India 5.3.3.4 Australia 5.3.3.5 Rest of Asia-Pacific 5.3.4 South America 5.3.4.1 Brazil 5.3.4.2 Argentina 5.3.4.3 Reat of South America 5.3.5 Middle East and Africa 5.3.5.1 South Africa 5.3.5.2 UAE 5.3.5.3 Rest of Middle East and Africa 6 COMPETITIVE LANDSCAPE 6.1 Most Adopted Strategies 6.2 Most Active Companies 6.3 Market Share Analysis 6.4 Company Profiles 6.4.1 Kewpie Corporation 6.4.2 Merck KGaA, Darmstadt 6.4.3 Bouwhuis-Enthoven 6.4.4 Lee BioSolutions 6.4.5 Bioseutica 6.4.6 Rembrandt Enterprises 6.4.7 Calzyme 6.4.8 HiMedia Laboratories 7 MARKET OPPORTUNITIES AND FUTURE TRENDS